An in-depth look to OPTUS PHARMACEUTICAL operating, investing, and financing activities

131030 free cash flow for Q3 24 is -7.75 B KRW. For 2023, 131030 free cash flow was 9.11 B KRW and operating cash flow was 12.44 B KRW.